Skip to main content

SANUWAVE Health Inc

For the period ended Dec 31, 2023. Filed Mar 21, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Mar 21, 2024

SNWV$1.85-15.5%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 16. Form 10-K Summary

The Company has elected not to include summary information.

SIGNATURES

Pursuant to the requirements of Section 13 of 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

SANUWAVE HEALTH, INC.
Dated: March 21, 2024By:/s/ Morgan Frank
Name: Morgan Frank
Title: Chief Executive Officer

POWER OF ATTORNEY

Know all persons by these presents, that each person whose signature appears below constitutes and appoints Morgan Frank and Toni Rinow, and each of them, as such person’s true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for such person and in such person’s name, place and stead, in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto, and all other documents in connection therewith, with the Securities and Exchange Commission, granting unto each said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as such person might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them or their or such person’s substitute or substitutes, may lawfully do or cause to be done by virtue thereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated:

SignaturesCapacityDate
By: /s/ Morgan Frank Name: Morgan FrankChief Executive Officer and Chairman of the Board of Directors (principal executive officer)March 21, 2024
By: /s/ Toni Rinow Name: Toni RinowChief Financial Officer (principal financial and accounting officer)March 21, 2024
By: /s/ Kevin Richardson, II Name: Kevin Richardson, IIDirectorMarch 21, 2024
By: /s/ A. Michael Stolarski Name: A. Michael StolarskiDirectorMarch 21, 2024
By: /s/ Jeff Blizard Name: Jeff BlizardDirectorMarch 21, 2024
By: /s/ Ian Miller Name: Ian MillerDirectorMarch 21, 2024
By: /s/ Jim Tyler Name: Jim TylerDirectorMarch 21, 2024
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.